Paterna Biosciences: Funding, Investors & Team (Sep 2026)
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant challenges of male infertility. We recognize the critical gap in male fertility treatment and are committed to helping people on their path to parenthood. Our innovative in-vitro spermatogenesis (IVS) technology is poised to transform the fertility landscape, offering new hope and innovative solutions to those struggling to conceive. Led by a team of world-renowned scientists and physicians, we are advancing research into clinical applications. Our mission is to make parenthood a reality for more families through ethical, scientifically advanced fertility solutions. Did you know? *1 in 8 couples struggle with infertility. *50% of in vitro fertilization (IVF) procedures fail. *50% of infertility is linked to men. *Male infertility treatment has been stagnant since 1992. Paterna is the first to develop a truly new treatment for male infertility since then. With a strong foundation in science and a commitment to innovation, Paterna BioSciences is uniquely positioned to lead the next generation of male fertility treatments. We are actively seeking funding to accelerate our clinical development and commercialization efforts, bringing our life-changing technology to families worldwide. We help make parenthood possible. Learn more at www.PaternaBio.
Paterna Biosciences has raised $12.3M across 2 funding rounds on record, the most recent a Series A of $6.3M announced in Aug 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Paterna Biosciences Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Paterna Biosciences Funding Rounds
Paterna Biosciences raised $6.0M in a Seed announced in Oct 2024.
1.8 years later, a Series A of $6.3M was announced in Aug 2026.
Paterna Biosciences Investors
6 investors are recorded in total; the 5 named above are those the record identifies.
Paterna Biosciences Founders and Leadership Team
Contact details for the Paterna Biosciences team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Paterna Biosciences Funding Compared to Other Biotechnology Startups
Paterna Biosciences' latest round of $6.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Paterna Biosciences in Biotechnology and Salt Lake City
Companies Similar to Paterna Biosciences
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in…
Paterna Biosciences Funding FAQs
What does Paterna Biosciences do?
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant challenges of male infertility. We recognize the critical gap in male fertility treatment and are committed to helping people on their path to parenthood. Our innovative in-vitro spermatogenesis (IVS) technology is poised to transform the fertility landscape, offering new hope and innovative solutions to those struggling to conceive. Led by a team of world-renowned scientists and physicians, we are advancing research into clinical applications. Our mission is to make parenthood a reality for more families through ethical, scientifically advanced fertility solutions. Did you know? *1 in 8 couples struggle with infertility. *50% of in vitro fertilization (IVF) procedures fail. *50% of infertility is linked to men. *Male infertility treatment has been stagnant since 1992. Paterna is the first to develop a truly new treatment for male infertility since then. With a strong foundation in science and a commitment to innovation, Paterna BioSciences is uniquely positioned to lead the next generation of male fertility treatments. We are actively seeking funding to accelerate our clinical development and commercialization efforts, bringing our life-changing technology to families worldwide. We help make parenthood possible. Learn more at www.PaternaBio.
How much funding has Paterna Biosciences raised?
Paterna Biosciences has raised $12.3M across 2 rounds on record. The most recent is a Series A of $6.3M announced in Aug 2026.
When did Paterna Biosciences last raise funding?
Paterna Biosciences' most recent funding round on record is a Series A of $6.3M, announced in Aug 2026.
Who has invested in Paterna Biosciences?
Investors on record for Paterna Biosciences include SpringTide Ventures, Divergent Capital, Seaside Ventures, e184, IVIRMA GLOBAL. FundedIQ records 6 investors in total.
Who founded Paterna Biosciences?
FundedIQ lists Alex Pastuszak (Cofounder, CEO), Ed Rowland (Founder) at Paterna Biosciences.
Where is Paterna Biosciences headquartered?
Paterna Biosciences is based in Salt Lake City, Utah, United States.
How many employees does Paterna Biosciences have?
Paterna Biosciences is in the 11-50 employee band.
When was Paterna Biosciences founded?
Paterna Biosciences was founded in 2020.
How does Paterna Biosciences' funding compare to other Biotechnology startups?
Paterna Biosciences' latest round of $6.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Paterna Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Paterna Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.